Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed May 20, 2025 · 10-Q · 50 days after period end · 0001641172-25-011815
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$668.56K | -$758.09K | -$1.34M | -$678.05K |
| EPS Diluted | -$0.42 | -$0.62 | -$1.39 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 20, 2025 · 50 d after period end
